Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Greenway Greenhouse Cannabis Corp. ( (TSE:GWAY) ) just unveiled an announcement.
In its 2025 year-in-review, Greenway highlighted a year of disciplined execution marked by improved cultivation efficiency, stronger yields and tighter cost controls, which management views as a durable step-change underpinning its profitability strategy. The company advanced its international wholesale program with product now reaching multiple European jurisdictions and Australia, and it signed a strategic supply agreement with 4C Labs to serve the U.K. medical cannabis market, while delivering a 20% increase in annual revenue and a more than 40% rise in average selling price per gram. With additional cultivation capacity already built out that can lift production by over 75% without significant new capital spending, Greenway plans to ramp output in a measured, demand-driven manner, aiming to leverage growing international sales channels to drive higher volumes, revenue growth and operating leverage despite ongoing volatility in the Canadian cannabis sector.
The most recent analyst rating on (TSE:GWAY) stock is a Hold with a C$0.18 price target. To see the full list of analyst forecasts on Greenway Greenhouse Cannabis Corp. stock, see the TSE:GWAY Stock Forecast page.
Spark’s Take on TSE:GWAY Stock
According to Spark, TipRanks’ AI Analyst, TSE:GWAY is a Neutral.
The score is primarily held back by weaker financial fundamentals—continued net losses, elevated leverage, and negative TTM operating/free cash flow—despite clear operating improvements. Technicals are mildly constructive in the near term but remain weaker over longer timeframes, while valuation is pressured by negative earnings. A recent positive corporate update provides incremental support but does not outweigh balance-sheet and cash-flow risks.
To see Spark’s full report on TSE:GWAY stock, click here.
More about Greenway Greenhouse Cannabis Corp.
Greenway Greenhouse Cannabis Corporation is a Canadian cultivator of high-quality greenhouse-grown cannabis, primarily serving the domestic Canadian market and increasingly targeting regulated international medical markets. Operating 2.5 acres of active cultivation with additional built-out capacity, the company focuses on cost-efficient, large-scale production and wholesale channels, including partnerships that support its expansion into Europe, Australia and the U.K. medical cannabis market.
Average Trading Volume: 16,829
Technical Sentiment Signal: Sell
Current Market Cap: C$23.8M
Learn more about GWAY stock on TipRanks’ Stock Analysis page.